Literature DB >> 6370693

Further study of biological activities of chemically synthesized analogues of lipid A in artificial membrane vesicles.

T Yasuda, S Kanegasaki, T Tsumita, T Tadakuma, N Ikewaki, J Y Homma, M Inage, S Kusumoto, T Shiba.   

Abstract

In the previous paper [Eur. J. Biochem. 124, 405 (1982)], we demonstrated that chemically synthesized lipid-A analogues such as the 1-monophosphate or 1,4'-diphosphate of 6-O-(2-deoxy-2-tetradecanoylamino-6-O-tetradecanoyl-D-glucopyra nos yl)-2-deoxy-2-tetradecanolyamino-3,4-di-O-tetradecanoyl-D-gluco pyr anose enhanced immunogenicity of liposomal model membranes sensitized with amphipathic antigen when they were incorporated in the same liposomes. Here we extend the observation by testing the recently synthesized analogues including diglucosamine analogues carrying hydroxy and acyloxy fatty acids. Among the analogues tested, those which showed higher adjuvant and mitogenic activities in the liposomal system were N-acylated and O-acylated beta-1,6-linked D-glucosamine disaccharides carrying either amide-bound 3-hydroxytetradecanoic acids in addition to phosphate in position 1 of the reducing sugar or amide-bound 3-tetradecanoyloxytetradecanoic acids. The analogue carrying both amide-bound 3-hydroxytetradecanoic acids and phosphate in position 4 of the non-reducing sugar showed weak adjuvant activity and marginal mitogenic activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370693     DOI: 10.1111/j.1432-1033.1984.tb08094.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  2 in total

1.  Protection of mice against lethal endotoxemia by a lipid A precursor.

Authors:  R A Proctor; J A Will; K E Burhop; C R Raetz
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

2.  Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs.

Authors:  H Takada; S Kotani; M Tsujimoto; T Ogawa; I Takahashi; K Harada; C Katsukawa; S Tanaka; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.